about
Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA-Q).Cognitive, behavioural and psychological barriers to the prevention of severe hypoglycaemia: A qualitative study of adults with type 1 diabetes.Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.Natural history, risk factors and clinical features of primary hypogonadism in ageing men: Longitudinal Data from the European Male Ageing Study.High levels of foot ulceration and amputation risk in a multiracial cohort of diabetic patients on dialysis therapyGenome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traitsWhat strategies are effective for exercise adherence in heart failure? A systematic review of controlled studies.Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease.Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men.The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline: Findings from the European Male Ageing Study.Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes.Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial.Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.Non-androgenic Anabolic Hormones Predict Risk Of Frailty: European Male Ageing Study Prospective Data.Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank.The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes.Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease.Prognostic Value of Adipokines in Predicting Cardiovascular Outcome: Explaining the Obesity Paradox.Well, I Wouldn't be Any Worse Off, Would I, Than I am Now? A Qualitative Study of Decision-Making, Hopes, and Realities of Adults With Type 1 Diabetes Undergoing Islet Cell TransplantationCardiovascular risk and the metabolic syndrome.'I should have taken that further' - missed opportunities during cardiovascular risk assessment in patients with psoriasis in UK primary care settings: a mixed-methods study.Motor unit number estimates and neuromuscular transmission in the tibialis anterior of master athletes: evidence that athletic older people are not spared from age-related motor unit remodeling.Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.Primary care-based screening for cardiovascular risk factors in patients with psoriasis.Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS).Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?Coronary revascularisation in the patient with diabetes: balancing risk and benefit.Glucose and insulin abnormalities in patients with heart failure.What can we learn from patients with heart failure about exercise adherence? A systematic review of qualitative papers.Incretins as a novel therapeutic strategy in patients with diabetes and heart failure.Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.Association analyses based on false discovery rate implicate new loci for coronary artery disease.Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014.Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups.Enhanced External Counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes.Ethnic differences in male reproductive hormones and relationships with adiposity and insulin resistance in older men.Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study.Interactions Between Depression and Lower Urinary Tract Symptoms: The Role of Adverse Life Events and Inflammatory Mechanisms. Results From the European Male Ageing Study.
P50
Q30279237-1652DF25-08A0-4621-B707-8A2F4F3D1DFCQ30361562-1E0EA20B-D488-4682-B271-E6D61AF4F3B2Q31095975-9D75BBF0-2AEE-44DC-9E0C-6ABFD264A39EQ31112152-FAB64955-0A17-4549-A630-F90CE728ECE4Q33751580-A19AA7B4-E948-4E7E-ADB5-C3EA02D81975Q33855009-8E3590AB-3DDF-45B6-8A3D-2935542C3F91Q33897868-FFE47503-54B3-49D6-A351-52F3F494B4B1Q34016073-5BB12FC1-7BC0-4F2A-8964-6313E3B44A52Q34404827-ACE22B3E-A887-4267-8699-4C062673B9B6Q34460537-4A66D025-649B-4F39-8303-01C9991388FFQ34507270-5CA89513-4764-4712-AD8D-89AA2DFD74B5Q34552670-63EBEE3D-17AC-4947-AF64-12C8A4354F46Q34726103-A8FFD434-A5D1-41B7-8F1B-FECDEAE04E99Q35264479-204E6DA6-E51C-4DE5-8C68-417C3949F8A8Q35999237-9DD9D19C-96F3-4AE3-91BA-82EBBD28238BQ36400630-407362DC-6182-4FF2-9B89-5B44156628E4Q36675167-EEA8138A-5939-4682-A671-149A9F32F21CQ36688354-A12C6EAD-F255-4FC1-9A51-9529ABE623C0Q36844077-179AD892-FD00-4A03-A585-BCB72AA97B7BQ37072058-A5D01CBA-0AA9-47C4-A8C6-668F792B822AQ37097817-D1FB6363-7834-4C67-B583-CD5DC5696266Q37120784-4C109652-61CB-44D8-852A-EADD5D709C16Q37316423-FB653691-FCCF-45EC-80E3-FB23FED6FE7FQ37339248-2C425FEC-53A2-48AD-9E71-76C42AB38FFCQ37398972-0D8D2A68-9589-4EB6-813D-11CC612DD81EQ37420435-BC752C39-5421-4F26-88DB-38B93E9AE740Q37610771-633E4389-C27C-42AC-AAB3-40B1C68A8E38Q37783432-BBBD221C-7123-484E-BA36-FA88FBA950EDQ37784929-94635E1D-CAB1-47C2-B110-C0A4E1BE7051Q37801130-FAA0EACD-8393-4923-B0C3-B41AAB0B0B1CQ37870916-2DFAA748-1251-43D3-99BF-18B73E65D772Q38008596-E22D7D6D-3407-4AD4-9A23-7430883D6938Q38647077-8DC82D4D-0C2A-48FD-8649-73600E37F3E0Q38675868-C3CC41C3-1430-40F1-B9AF-644BAA2F9AC1Q38848552-8149E4C6-560A-478C-86F8-E5370B804C5EQ39080929-04334AE9-76A3-47D6-9E21-804CD4B5FE1DQ39390974-59D84570-8D01-453D-9FA5-B96A5FEDCFC1Q40350187-DAEB3042-C68F-4AB8-90E0-53A099C74A00Q40670854-6CE63E80-83EC-4220-85BB-CED1C413F462Q40811531-7C07F37D-AE8E-4622-97B0-BB47E635CC27
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Martin Rutter
@ast
Martin Rutter
@en
Martin Rutter
@es
Martin Rutter
@nl
Martin Rutter
@sl
Мартин Раттер
@ru
type
label
Martin Rutter
@ast
Martin Rutter
@en
Martin Rutter
@es
Martin Rutter
@nl
Martin Rutter
@sl
Мартин Раттер
@ru
prefLabel
Martin Rutter
@ast
Martin Rutter
@en
Martin Rutter
@es
Martin Rutter
@nl
Martin Rutter
@sl
Мартин Раттер
@ru
P106
P1153
7201521766
P21
P31
P496
0000-0001-6380-539X